Assignee
WUHAN NEUROPHTH BIOTECHNOLOGY LTD COMPANY
CN·4 granted patents·4 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
8 records- 0172US11357869B2Compositions and methods for treating leber's hereditary optic neuropathy with NADH dehydrogenase proteinsWUHAN NEUROPHTH BIOTECHNOLOGY LTD COMPANY·Filed 2021·Granted Jun 14, 2022·0 cites·29 claims
- 0271US11332741B1Compositions and methods for treating leber's hereditary optic neuropathyWUHAN NEUROPHTH BIOTECHNOLOGY LTD COMPANY·Filed 2021·Granted May 17, 2022·0 cites·21 claims
- 0369US2022273816A1Compositions and methods for treating leber's hereditary optic neuropathy with nadh dehydrogenase proteinsWUHAN NEUROPHTH BIOTECHNOLOGY LTD COMPANY·Filed 2022·Application pending·0 cites
- 0467US11352645B2Compositions and methods for treating Leber's hereditary optic neuropathyWUHAN NEUROPHTH BIOTECHNOLOGY LTD COMPANY·Filed 2021·Granted Jun 7, 2022·0 cites·27 claims
- 0567US2022259619A1Compositions and methods for treating leber's hereditary optic neuropathyWUHAN NEUROPHTH BIOTECHNOLOGY LTD COMPANY·Filed 2022·Application pending·0 cites
- 0665US11459584B2Gene sequence of recombinant human type II mitochondrial dynein-like GTPase and uses thereofWUHAN NEUROPHTH BIOTECHNOLOGY LTD COMPANY·Filed 2021·Granted Oct 4, 2022·0 cites·24 claims
- 0763US2024376164A1Compositions and methods for treating leber's hereditary optic neuropathy caused by nd4 mutationWUHAN NEUROPHTH BIOTECHNOLOGY LTD COMPANY·Filed 2022·Application pending·0 cites
- 0852US2024209391A1Expression vector for human nuclear factor erythroid 2-related factor 2 (nrf2) and application thereofWUHAN NEUROPHTH BIOTECHNOLOGY LTD COMPANY·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when WUHAN NEUROPHTH BIOTECHNOLOGY LTD COMPANY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →